For the last 150 years, the diagnosis of mental health and cognitive issues has relied upon patient/family self-reporting. Today there is finally a clinical tool available that can provide critical diagnostic information based on objective, quantifiable measures of brain function.
Improve your patient care using the newest technological breakthroughs in quantitative EEG and Artificial Intelligence.
And the best part? It can be done quickly at our outpatient clinic and is fully covered by insurance.
Until now, EEG-based brain assessment technology available was expensive, labor intensive, and impractical. The ability to rapidly, inexpensively, and reliably measure the functional health of the brain is critical for identifying serious medical and behavioral health conditions.
Brain mapping can be done every 4 to 6 months as an objective way to monitor a patient’s response to treatment, and is covered by all insurance plans.
Take advantage of a powerful new FDA-approved tool used to help evaluate and diagnose individuals with behavioral health issues, addiction disorders, neurological or cognitive deficiencies, and traumatic brain injuries.
Quantitative EEG brain mapping is a new tool for physicians and behavioral health specialists to help diagnose and treat changes in cognitive function and psychological health.
It provides objective, quantifiable measures of brain function and potential pathologies in an outpatient setting, rather than traditional methods of relying on subjective patient reporting.
Due to its high sensitivity, brain mapping can identify important issues that the patient may not have disclosed, gauge the severity of symptoms, and monitor gradual changes in mental health that may otherwise go undetected during treatment.
Brain mapping is non‐invasive, low‐cost and easy to do. It allows healthcare providers to visualize locations in the brain that are not functioning optimally and aids in diagnosis and treatment.
By giving patients concrete data that they can see and understand, and with more sensitivity and comprehensive results than traditional subjective screening tests, patients are better able to understand their diagnoses and progress. This helps motivate patients to adhere to early, life‐changing interventions.
Brain mapping is uniquely helpful for tracking a patient’s response to treatment. It can be repeated every 4 to 6 months and provides valuable insight for healthcare providers to objectively measure a patient’s response to:
If you have a client or patient who may benefit from brain mapping, please refer them to Foundation Medical Group for more information. Both the referring healthcare provider and the patient will receive a copy of the final report and one of our specialists will be available to review the information with you and answer questions as needed.
Our quantitative EEG brain mapping technology is a USA FDA 510(K) cleared Class II medical device. Our leading‐edge brain scans are performed by healthcare providers and technicians who are expertly trained to conduct the tests in a safe, confidential, and professional environment. Our team will ensure the experience is easy and comfortable for your clients.
Since 2014 our network of clinicians has worked at the interface of behavioral health and medical science. We strive for opportunities to support and collaborate with other healthcare providers in our communities.
